Aptamer Group PLC

Here is the public summary page for Aptamer Group PLC. Please login to see the complete information for Aptamer Group PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Aptamer Group PLC stacks up relative to its peers.


Darwin Score+12
TickerAPTA
Latest Price0.01 GBP as of close on 15-Aug-2025
3 Month price range0.00 to 0.01 GBP
Market Capitalisation17.30Mn GBP
CountryUK
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
Aptamer Group PLC, together with its subsidiaries, provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers; and Optimer +, a platform that discovers and develops of hybrid DNA-protein molecules that combines the features of Optimer and antibodies. It serves bioprocessing and diagnostic institutes, as well as pharmaceutical scientists. The company has strategic partnership with Unilever for the development of Optimer for use in deodorant, Neuro-Bio to develop reagents for Alzheimer's disease test, and other pharma partner and AztraZeneca for drug delivery vehicle for fibrotic liver. The company was founded in 2008 and is headquartered in York, the United Kingdom.
See More ...
Company URLhttps://aptamergroup.com
See Darwins Full Analysis for Aptamer Group PLC

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Aptamer Group PLC. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+32
SentimentNews and Candle Patterns. -1
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.-1
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.-18

Alerts

There are 14 live alerts for Aptamer Group PLC.


Peer Comparison

There are 29 peers of Aptamer Group PLC.
Asset NameIndustry GroupPerf(20d)%Asset Score
4BASEBIO UK SOCIETAS (4BB)Biotechnology-8.6-14
Abingdon Health Plc (ABDX)Biotechnology0-25
Alliance Pharma plc (APH)Biotechnology+0.8+31
Angle PLC (AGL)Biotechnology-15.4-18
Arecor Therapeutics PLC (AREC)Biotechnology+29.6+6
Avacta Group PLC (AVCT)Biotechnology+47.7+16
BSF Enterprise Plc (BSFA)Biotechnology+1.2-16
Benchmark Holdings Plc (BMK)Biotechnology-10.7-18
Beximco Pharmaceuticals Limited (BXP)Biotechnology+20.3+32
BiVictriX Therapeutics PLC (BVX)Biotechnology+21.2+2
Bioventix (BVXP)Biotechnology-15.6+2
Celadon Pharmaceuticals PLC (CEL)Biotechnology0-8
Chill Brands Group PLC (CHLL)Biotechnology-2.3-21
Cizzle Biotechnology Holdings PLC (CIZ)Biotechnology-18.8-15
Destiny Pharma PLC (DEST)Biotechnology-7.7-30
Diaceutics PLC (DXRX)Biotechnology+7.0+17
Evgen Pharma PLC (EVG)Biotechnology-8.6-7
Faron Pharmaceuticals Oy (FARN)Biotechnology+2.4+12
Genflow Biosciences plc (GENF)Biotechnology-10.7-27
Genincode PLC (GENI)Biotechnology-26.3-21
Genus PLC (GNS)Biotechnology+8.3+20
Haleon PLC (HLN)Biotechnology0+4
Ondine Biomedical Inc (OBI)Biotechnology+25.0+14
Oxford BioMedica PLC (OXB)Biotechnology+33.6+41
Oxford Nanopore Technologies PLC (ONT)Biotechnology+43.5+8
Physiomics PLC (PYC)Biotechnology-10.5-9
Shield Therapeutics PLC (STX)Biotechnology+59.2+20
e-therapeutics plc (ETX)Biotechnology-28.0-4
genedrive plc (GDR)Biotechnology-39.3-8

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn